From: Patients on subcutaneous allergen immunotherapy are at risk of intramuscular injections
STMD
Number of patients (n)
Proportion of patients (%)
> 4 mm
182
91
> 6 mm
149
75
> 8 mm
110
55
> 10 mm
74
37